Cancer TherapyConfirmed
One Dose of a Breast Cancer Recurrence Drug Matched Seven in a Smaller Trial
Ottawa researchers reported that one zoledronate dose matched a multi-dose schedule over five years in a specific postmenopausal early breast cancer trial.
Why now
This is a rare good-news cancer story where the possible breakthrough is less treatment burden, not more intervention.
- Overclaim risk
- medium
- Primary source
- Official
- Published
- Jun 27, 2026